Fetal hemoglobin per erythrocyte (HbF/F-cell) after gene therapy for sickle cell anemia

Am J Hematol. 2023 Feb;98(2):E32-E34. doi: 10.1002/ajh.26791. Epub 2022 Nov 30.

Authors

Paola Sebastiani¹, Martin H Steinberg²

Affiliations

¹ Institute for Clinical Research and Health Policy Studies, Center for Quantitative Methods and Data Science, Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts, USA.
² Department of Medicine, Division of Hematology and Medical Oncology, Boston University Chobanian and Avedisian School of Medicine and Boston Medical Center, Boston, Massachusetts, USA.

PMID: 36420999
DOI: 10.1002/ajh.26791

No abstract available

Publication types

Letter

MeSH terms

Anemia, Sickle Cell* / genetics
Anemia, Sickle Cell* / therapy
Erythrocytes
Fetal Hemoglobin* / analysis
Fetal Hemoglobin* / genetics
Genetic Therapy / adverse effects
Hemoglobin, Sickle / genetics
Humans

Substances

Fetal Hemoglobin
Hemoglobin, Sickle